FDAnews
www.fdanews.com/articles/114668-two-minnesota-firms-refining-lower-cost-option-to-stent

Two Minnesota Firms Refining Lower-Cost Option to Stent

February 16, 2009
Lutonix and Possis are each at work on drug-coated balloons, which studies suggest could pose fewer risks of clots than drug-coated stents.
StarTribune.com